Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stig Agurell is active.

Publication


Featured researches published by Stig Agurell.


Journal of Pharmacy and Pharmacology | 1973

Quantitation of Δ1‐tetrahydrocannabinol in plasma from cannabis smokers

Stig Agurell; Bertil Gustafsson; Bo Holmstedt; Kurt Leander; Jan-Erik Lindgren; Inger M. Nilsson; Finn Sandberg; Marie Asberg

A method to identify and accurately measure non‐labelled Δ1‐tetrahydrocannabinol (Δ1‐THC) in blood of cannabis smokers has been developed. It consists of the following steps: To a 5 ml plasma sample is added deuterated Δ1‐THC (Δ1‐THC‐d2) as internal standard. After extraction with light petroleum and evaporation, the Δ1‐THC containing fraction is separated by chromatography on Sephadex LH‐20 (1 times 40 cm) using light petroleum‐chloroform‐ethanol (10:10:1) as eluant. A fraction containing Δ1‐THC is collected and subjected to mass fragmentography (LKB 9000; 3% OV‐17/Gas‐Chrom Q; 230°). The mass spectrometer was adjusted to record the intensities of m/e 299 and 314 of Δ1‐THC and m/e 301 and 316 of Δ1‐THC‐d2. The standard curve was made by plotting peak height m/e 299/m/e 301. Peak levels of 19–26 ng ml−1 were reached within 10 min after smoking a cigarette containing 10 mg Δ1‐THC.


Journal of Pharmacy and Pharmacology | 1976

Identification of monohydroxylated metabolites of cannabidiol formed by rat liver.

Bill Martin; Marianne Nordqvist; Stig Agurell; Jan-Erik Lindgren; Kurt Leander; Michael Binder

Cannabidiol (CBD) was metabolized in vitro by rat liver enzymes. Unchanged CBD and eight monohydroxylated metabolites were isolated and positively identified. As previously reported, 7‐hydroxy‐CBD was the major metabolite. The second most abundant metabolite was 6α‐hydroxy‐CBD; whereas only a trace amount of 6β‐hydroxy‐CBD was found. In addition hydroxylation occurred in all positions of the pentyl side chain, 4″‐hydroxy‐CBD being most abundant. 3″‐Hydroxy‐CBD was formed in half of the yield of 4″‐hydroxy‐CBD, while 1″‐, 2″‐, and 5″‐hydroxy‐CBD were each formed in approximately one fourth of the yield of 4″‐hydroxy‐CBD.


Archives of Biochemistry and Biophysics | 1962

Biogenetic interrelationships of ergot alkaloids.

Stig Agurell; Egil Ramstad

Abstract The biogenetic interconversions of clavine alkaloids have been studied by the use of clavine-C14 and clavine-H3 alkaloids labeled biosynthetically in saprophytic culture, and four different ergot strains in saprophytic cultures. Agroclavine was shown to be oxidized irreversibly to elymoclavine. The attack appears to be directly on the methyl group. Agroclavine, but not elymoclavine, was shown to be converted irreversibly to the following clavine alkaloids: festuclavine, pyroclavine, and setoclavine. Elymoclavine was shown to be the precursor of lysergol, isolysergol, penniclavine, and isopenniclavine. These conversion reactions are irreversible. Only three clavine alkaloids were found to be metabolized in ergot strain 47 A, viz., agroclavine, elymoclavine, and lysergene, all of which have a double bond in position 8. Chanoclavine was shown not to be a precursor of the clavine alkaloids. Evidences indicate that it was not a breakdown product of agroclavine or of any other clavine alkaloid derived from agroclavine. Lysergene was shown to be converted to lysergol, isolysergol, penniclavine, and isopenniclavine. No evidence was found suggesting that lysergene is a normal intermediate in the biosynthesis of these compounds from elymoclavine. Each stereoisomer was found to be biosynthesized as such and not to be the result of a chemical or biochemical isomerization process.


Biochemical Pharmacology | 1974

Biliary excretion of Δ1-tetrahydrocannabinol and its metabolites in the rat☆

Marianne Widman; Marianne Nordqvist; Stig Agurell; Jan-Erik Lindgren; Finn Sandberg

Abstract Δ1-Tetrahydrocannabinol (Δ1-THC) administered i.v. (1 mg/kg) to anaesthetized rats with cannulated bile ducts is rapidly eliminated as metabolites in the bile. 60–70 per cent in 6 hr. In comparison with the slow excretion via faeces an extensive enterohepatic circulation, which may be of toxicological importance, is indicated. Unchanged Δ1-THC and cannabinol are eliminated in low amounts (0.05 0.1 percent) in the bile. A few per cent consists of two or more mono-oxygenated metabolites. neither of which is identical with 7-hydroxy-Δ1-THC or 6-β-hydroxy-Δ1-THC. The main part of the non-conjugated metabolites is present as compounds more polar than 7-hydroxy-Δ1-THC and as carboxylic acids. These acids were more polar than Δ1-THC-7-oic acid which could not be identified in a free or conjugated form. In the rat about 60 per cent of the metabolites are eliminated as water-soluble conjugates. Hydrolysis with glucuronidase liberated aglycones which were mainly neutral whereas hydrolysis with alkali released neutral but also some acidic compounds. 7-Hydroxy-Δ1-THC was identified as an aglycone of glucuronic acid and furthermore, three mono-oxygenated cannabinoids were isolated after hydrolysis and partially characterized.


Archive | 1976

Effects of Cannabinoids on Isolated Smooth Muscle Preparations

Sune Rosell; Stig Agurell; Billy Martin

To investigate the mechanisms of action of the psychoactive cannabinoids, one can use isolated peripheral tissues as test preparations, provided that there is a close chemical relationship between the acute behavioral actions and the effects on the isolated organ. In addition, the cannabinoids should be active in concentrations that produce the behavioral effects. To find such a tissue, we have tested the effects of cannabinoids on a number of isolated preparations.


Acta Chemica Scandinavica | 1969

Alkaloids in Certain Species of Virola and Other South American Plants of Ethnopharmacologic Interest.

Stig Agurell; Holmstedt B; Lindgren Je; Schultes Re


Helvetica Chimica Acta | 1974

Zur Identifikation potentieller Metabolite von Cannabis-Inhaltstoffen: Kernresonanz- und massenspektroskopische Untersuchungen an seitenkettenhydroxylierten Cannabinoiden

Michael Binder; Stig Agurell; Kurt Leander; Jan-Erik Lindgren


Biochemical Pharmacology | 1968

Identification of two new β-carboline alkaloids in South American hallucinogenic plants

Stig Agurell; Bo Holmstedt; Jan-Erik Lindgren; Schultes Re


Journal of Chromatography A | 1968

Gas chromatography of peyote alkaloids. A new peyote alkaloid

Jan Lundström; Stig Agurell


Acta Chemica Scandinavica | 1969

Synthesis of 3H- and 14C-labelled Tetrahydrocannabinols.

J. Lars G. Nilsson; Inger M. Nilsson; Stig Agurell; Vegard Nordal; Alf A. Lindberg; J. Cymerman Craig

Collaboration


Dive into the Stig Agurell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. Lars G. Nilsson

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Naftali Lander

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Raphael Mechoulam

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Z. Ben-Zvi

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge